GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Beneish M-Score

Next Science (ASX:NXS) Beneish M-Score : -1.97 (As of Jan. 18, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Next Science Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.97 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Next Science's Beneish M-Score or its related term are showing as below:

ASX:NXS' s Beneish M-Score Range Over the Past 10 Years
Min: -2.42   Med: -1.84   Max: -1.65
Current: -1.97

During the past 6 years, the highest Beneish M-Score of Next Science was -1.65. The lowest was -2.42. And the median was -1.84.


Next Science Beneish M-Score Historical Data

The historical data trend for Next Science's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Beneish M-Score Chart

Next Science Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -1.65 -1.70 -2.42 -1.97

Next Science Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -2.42 - -1.97 -

Competitive Comparison of Next Science's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Next Science's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Next Science's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Next Science's Beneish M-Score falls into.



Next Science Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Next Science for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0901+0.528 * 1.0671+0.404 * 0.6895+0.892 * 1.9088+0.115 * 0.8004
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8673+4.679 * -0.071794-0.327 * 0.8821
=-1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was A$5.36 Mil.
Revenue was A$33.14 Mil.
Gross Profit was A$24.26 Mil.
Total Current Assets was A$20.86 Mil.
Total Assets was A$26.74 Mil.
Property, Plant and Equipment(Net PPE) was A$2.27 Mil.
Depreciation, Depletion and Amortization(DDA) was A$1.66 Mil.
Selling, General, & Admin. Expense(SGA) was A$38.51 Mil.
Total Current Liabilities was A$5.73 Mil.
Long-Term Debt & Capital Lease Obligation was A$1.03 Mil.
Net Income was A$-24.31 Mil.
Gross Profit was A$0.11 Mil.
Cash Flow from Operations was A$-22.50 Mil.
Total Receivables was A$2.58 Mil.
Revenue was A$17.36 Mil.
Gross Profit was A$13.56 Mil.
Total Current Assets was A$12.25 Mil.
Total Assets was A$18.47 Mil.
Property, Plant and Equipment(Net PPE) was A$2.59 Mil.
Depreciation, Depletion and Amortization(DDA) was A$1.33 Mil.
Selling, General, & Admin. Expense(SGA) was A$23.26 Mil.
Total Current Liabilities was A$3.86 Mil.
Long-Term Debt & Capital Lease Obligation was A$1.43 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5.362 / 33.135) / (2.577 / 17.359)
=0.161823 / 0.148453
=1.0901

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(13.56 / 17.359) / (24.255 / 33.135)
=0.781151 / 0.732005
=1.0671

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (20.856 + 2.265) / 26.743) / (1 - (12.246 + 2.593) / 18.466)
=0.135437 / 0.196415
=0.6895

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=33.135 / 17.359
=1.9088

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.329 / (1.329 + 2.593)) / (1.663 / (1.663 + 2.265))
=0.338858 / 0.423371
=0.8004

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(38.509 / 33.135) / (23.26 / 17.359)
=1.162185 / 1.339939
=0.8673

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.026 + 5.732) / 26.743) / ((1.426 + 3.864) / 18.466)
=0.252702 / 0.286472
=0.8821

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-24.309 - 0.109 - -22.498) / 26.743
=-0.071794

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Next Science has a M-score of -1.97 suggests that the company is unlikely to be a manipulator.


Next Science Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Next Science's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Next Science Business Description

Traded in Other Exchanges
Address
264-278 George Street, Level 14, Australia Square, HWL Ebsworth, Sydney, NSW, AUS, 2000
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.

Next Science Headlines

No Headlines